03 — Epigenetic alterations
Primary hallmark ("damage") according to López-Otín et al., Cell 2023 (doi:10.1016/j.cell.2022.11.001).
1. Definition
Age-related drift of the chemical marks that control which genes are switched on or off without changing the DNA sequence: DNA methylation, histone modifications, chromatin organisation, non-coding RNAs. This drift blurs the identity and function of cells. It increases with age, is worsened by DNA lesions, and its correction (partial reprogramming) rejuvenates tissues in animals (Sen 2016, doi:10.1016/j.cell.2016.07.050; Pal & Tyler 2016, doi:10.1126/sciadv.1600584).
In plain terms: all our cells have the same DNA (the "recipe book"). Epigenetics is the bookmarks and sticky notes that tell each cell which pages to read. With age, the sticky notes come off or move: the skin or liver cell reads "its" recipes less and less well.
2. Mechanisms and sources
Main alterations observed with age
- DNA methylation: global loss of methylation (especially in repeated regions) and local gain at some promoters (often developmental genes, targets of Polycomb proteins). These changes are so regular that they can be used to build "epigenetic clocks" (section 3).
- Histones and chromatin: loss of histones, redistribution of active and repressive marks (e.g. H3K9me3, H3K27me3, H4K16ac), erosion of the heterochromatin that keeps repeated regions silent (Sen 2016).
- Awakening of retrotransposons: loss of heterochromatin lets LINE-1 elements be expressed, which triggers an inflammatory interferon response (De Cecco 2019, doi:10.1038/s41586-018-0784-9).
- Drift between individuals: monozygotic twins have almost identical epigenetic profiles when young, which diverge with age and lifestyle (Fraga 2005, doi:10.1073/pnas.0500398102). Part of the drift is therefore stochastic or environmental.
Origins
- DNA repair: when a break is repaired, chromatin factors (including sirtuins) leave their post to go to the lesion and do not always return to the right place. The "ICE" mouse model (double-strand breaks induced without mutations) is enough to accelerate epigenetic and physiological aging; reprogramming with OSK reverses it. This is the central argument of the "information theory of aging" (Yang 2023, doi:10.1016/j.cell.2022.12.027).
- Metabolism: epigenetic enzymes use metabolites (acetyl-CoA, S-adenosylmethionine, NAD+, α-ketoglutarate). The decline of NAD+ with age reduces the activity of sirtuins (NAD+-dependent deacetylases).
- Environment: tobacco, diet and inflammation modify the marks.
3. Symptoms and clinical manifestations
Epigenetic alterations do not produce an isolated "disease"; they are mainly visible through epigenetic clocks, which serve as biomarkers.
| Clock | Principle | What it predicts | Source |
|---|---|---|---|
| Hannum (2013) | 71 CpG sites in blood | Chronological age | Hannum 2013, doi:10.1016/j.molcel.2012.10.016 |
| Horvath (2013) | 353 CpGs, all tissues | Chronological age, multi-tissue | Horvath 2013, doi:10.1186/gb-2013-14-10-r115 |
| PhenoAge (2018) | Trained on clinical markers | Mortality, morbidity | Levine 2018, doi:10.18632/aging.101414 |
| GrimAge (2019) | Surrogates of plasma proteins + smoking | Mortality, time to disease | Lu 2019, doi:10.18632/aging.101684 |
| DunedinPACE (2022) | Rate of decline of 19 markers followed over 20 years | Pace of aging | Belsky 2022, doi:10.7554/eLife.73420 |
In plain terms: an epigenetic clock reads a few hundred "sticky notes" on the DNA from a blood sample and infers a biological age. If it gives 55 years to a 50-year-old, this is called epigenetic "acceleration".
Human evidence: acceleration of second-generation clocks (PhenoAge, GrimAge) is associated in large cohorts with higher mortality, cardiovascular disease, cancer and cognitive decline (Levine 2018; Lu 2019). Progeroid syndromes show epigenetic acceleration: Werner syndrome with several clocks (Maierhofer 2017, doi:10.18632/aging.101217); Hutchinson-Gilford progeria with the "skin & blood" clock, but not with the 2013 multi-tissue clock (Horvath 2018, doi:10.18632/aging.101508). The review by Horvath & Raj (2018, doi:10.1038/s41576-018-0004-3) summarises these associations and proposes an "epigenetic clock theory": the clock would reflect developmental programmes that continue after maturity.
Associated diseases: cancers (hypermethylation of tumour suppressor genes, DNMT3A/TET2 mutations in clonal haematopoiesis, see file 01), chronic inflammatory diseases, neurodegeneration.
4. Interactions with the other hallmarks
| Hallmark (2023 numbering) | Link with epigenetic alterations |
|---|---|
| 1. Genomic instability | DNA breaks cause epigenetic drift (Yang 2023); conversely, loss of heterochromatin awakens LINE-1, a source of instability (De Cecco 2019). |
| 2. Telomere attrition | Telomeric heterochromatin degrades with age; its loss weakens telomeres. |
| 4. Loss of proteostasis | Histones and chromatin factors depend on chaperones; chaperone expression is itself epigenetically regulated. |
| 6. Deregulated nutrient sensing | NAD+, acetyl-CoA and SAM link nutritional state to the marks; caloric restriction slows epigenetic drift in mice and modestly in humans (Waziry 2023, doi:10.1038/s43587-022-00357-y). |
| 7. Mitochondrial dysfunction | Mitochondria supply the metabolites (acetyl-CoA, α-ketoglutarate) used by epigenetic enzymes. |
| 8. Cellular senescence | Senescence comes with a massive reorganisation of chromatin (heterochromatin foci, awakening of LINE-1). |
| 9. Stem cell exhaustion | Old stem cells lose their epigenetic identity; mutated DNMT3A/TET2 → blood clones. |
| 10. Altered intercellular communication | In heterochronic parabiosis (circulations of a young and an old mouse joined), the epigenetic age of the young mouse rises and then falls again after separation; stress (surgery, pregnancy, severe COVID-19) also raises it reversibly in humans (Poganik 2023, doi:10.1016/j.cmet.2023.03.015). |
| 11. Chronic inflammation | LINE-1 → interferons; inflammation accelerates the clocks (GrimAge includes inflammatory markers). |
| 12. Dysbiosis | The microbiota produces metabolites (butyrate, a histone deacetylase inhibitor); link with aging poorly documented [to verify]. |
5. Existing or investigational remedies
| Intervention | Target | Level of evidence | Key result | Source |
|---|---|---|---|---|
| Cyclic partial reprogramming (OSKM) | Restore the young epigenetic profile | Preclinical (progeroid mice) | Cyclic expression of 4 Yamanaka factors: improvement of several organs and about +30 % lifespan | Ocampo 2016, doi:10.1016/j.cell.2016.11.052 |
| Partial reprogramming (OSK, AAV) in the eye | Retinal neurons | Preclinical (mice) | Restores vision in old or glaucomatous mice, rejuvenates the methylation clock | Lu 2020, doi:10.1038/s41586-020-2975-4 |
| Long-term partial reprogramming (normal mice) | Whole body | Preclinical | Rejuvenation of molecular signatures (skin, kidney) without tumours in the protocol used | Browder 2022, doi:10.1038/s43587-022-00183-2 |
| — Risk of reprogramming | — | Preclinical | Complete or poorly controlled reprogramming → teratomas and cancers | Abad 2013, doi:10.1038/nature12586; Ohnishi 2014, doi:10.1016/j.cell.2014.01.005 |
| Moderate caloric restriction (CALERIE, ~12 % over 2 years) | Nutrients → epigenome | Human randomised trial (phase 2) | Modest slowing of DunedinPACE (~2-3 %); no effect on PhenoAge or GrimAge | Waziry 2023 |
| GH + DHEA + metformin (TRIIM) | Thymus regeneration | Uncontrolled pilot trial (9 men) | Epigenetic age ~2.5 years younger after 1 year; very small sample | Fahy 2019, doi:10.1111/acel.13028 |
| Diet + lifestyle programme (8 weeks) | Methylation | Randomised pilot trial (43 men) | Horvath clock ~3 years younger vs control, between-group difference not significant at the 5 % level | Fitzgerald 2021, doi:10.18632/aging.202913 |
| NAD+ precursors | Sirtuins | Preclinical; human phase 1-2 trials | See file 01; no demonstrated effect on clocks in humans [to verify] | — |
Finding: partial reprogramming is the most spectacular lead in animals, but remains preclinical, with a real tumour risk. In humans, effects on the clocks are modest, come from small trials, and it is unknown whether "rejuvenating the clock" improves health.
6. Open questions
- Cause or marker? Do the clocks measure a causal process or a mere reflection? Yang 2023 suggests causality in mice; not demonstrated in humans.
- Which biomarker to use as a trial endpoint? The clocks diverge from one another (CALERIE: effect on DunedinPACE, not on GrimAge).
- Safety of reprogramming: dose, duration, tissue, vector; how to avoid teratomas and loss of cell identity (Abad 2013; Ohnishi 2014)?
- Where is the "youth information" that reprogramming restores stored?
- Stochastic vs programmed share of the drift (Fraga 2005 vs the programme theory of Horvath & Raj 2018).
7. References
- López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell 2023. doi:10.1016/j.cell.2022.11.001
- Sen P, et al. Epigenetic mechanisms of longevity and aging. Cell 2016. doi:10.1016/j.cell.2016.07.050
- Pal S, Tyler JK. Epigenetics and aging. Sci Adv 2016. doi:10.1126/sciadv.1600584
- De Cecco M, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 2019. doi:10.1038/s41586-018-0784-9
- Fraga MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. PNAS 2005. doi:10.1073/pnas.0500398102
- Yang JH, et al. Loss of epigenetic information as a cause of mammalian aging. Cell 2023. doi:10.1016/j.cell.2022.12.027
- Hannum G, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013. doi:10.1016/j.molcel.2012.10.016
- Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013. doi:10.1186/gb-2013-14-10-r115
- Levine ME, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 2018. doi:10.18632/aging.101414
- Lu AT, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 2019. doi:10.18632/aging.101684
- Belsky DW, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 2022. doi:10.7554/eLife.73420
- Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet 2018. doi:10.1038/s41576-018-0004-3
- Waziry R, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging 2023. doi:10.1038/s43587-022-00357-y
- Ocampo A, et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 2016. doi:10.1016/j.cell.2016.11.052
- Lu Y, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 2020. doi:10.1038/s41586-020-2975-4
- Browder KC, et al. In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice. Nat Aging 2022. doi:10.1038/s43587-022-00183-2
- Abad M, et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 2013. doi:10.1038/nature12586
- Ohnishi K, et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 2014. doi:10.1016/j.cell.2014.01.005
- Fahy GM, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging Cell 2019. doi:10.1111/acel.13028
- Fitzgerald KN, et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging 2021. doi:10.18632/aging.202913
- Maierhofer A, et al. Accelerated epigenetic aging in Werner syndrome. Aging 2017. doi:10.18632/aging.101217
- Horvath S, et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford progeria syndrome and ex vivo studies. Aging 2018. doi:10.18632/aging.101508
- Poganik JR, et al. Biological age is increased by stress and restored upon recovery. Cell Metab 2023. doi:10.1016/j.cmet.2023.03.015
DOIs verified via the Crossref API on 2026-10-19.